|
SLC5A3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.47839999972999E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.47759999966379E-07 |
| Normal-vs-Stage2 |
3.37060000021872E-07 |
| Normal-vs-Stage3 |
3.08950000027508E-07 |
| Normal-vs-Stage4 |
5.17479999961878E-07 |
| Stage1-vs-Stage2 |
6.616800E-01 |
| Stage1-vs-Stage3 |
5.439600E-01 |
| Stage1-vs-Stage4 |
8.978000E-01 |
| Stage2-vs-Stage3 |
8.910000E-01 |
| Stage2-vs-Stage4 |
6.276000E-01 |
| Stage3-vs-Stage4 |
5.604600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.10810000017747E-07 |
| Normal-vs-AfricanAmerican |
5.27289999996405E-07 |
| Normal-vs-Asian |
4.60340000008053E-07 |
| Caucasian-vs-AfricanAmerican |
6.832800E-01 |
| Caucasian-vs-Asian |
9.715400E-01 |
| AfricanAmerican-vs-Asian |
8.364600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.17090000034881E-07 |
| Normal-vs-Female |
1.18250000002984E-06 |
| Male-vs-Female |
2.148100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.65779999961435E-07 |
| Normal-vs-Extreme_Weight |
3.933900000197E-07 |
| Normal-vs-Obese |
5.88769999976257E-07 |
| Normal-vs-Extreme_Obese |
2.59210000019827E-07 |
| Normal_Weight-vs-Extreme_Weight |
5.999600E-01 |
| Normal_Weight-vs-Obese |
9.635600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.553200E-01 |
| Extreme_Weight-vs-Obese |
5.342600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.753200E-01 |
| Obese-vs-Extreme_Obese |
1.689620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.02220000000697E-06 |
| Normal-vs-Age(41-60Yrs) |
7.20399999987187E-07 |
| Normal-vs-Age(61-80Yrs) |
2.92479999997042E-07 |
| Normal-vs-Age(81-100Yrs) |
1.40569999973472E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.412600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.011800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.070460E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.495700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.160300E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.953700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.76050000028272E-07 |
| Normal-VS-Type2 PRCC |
2.53640000003053E-07 |
| Normal-VS-KIRP CIMP |
3.89760000000239E-05 |
| Normal-VS-Unclassified PRCC |
3.22600000046691E-07 |
| Type1 PRCC-VS-Type2 PRCC |
1.931750E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.26649999999218E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
5.549200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.783300E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.904200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.982800E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.86109999972462E-07 |
| Normal-vs-N1 |
1.23600000001556E-06 |
| Normal-vs-N2 |
1.78439999999336E-05 |
| N0-vs-N1 |
6.114500E-02 |
| N0-vs-N2 |
5.664600E-01 |
| N1-vs-N2 |
9.364200E-01 |
|
|
